Jibok Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 1.50 M
- Company Age 17 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.00 M
About Jibok Pharmaceuticals
Jibok Pharmaceuticals Private Limited (JPPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 October 2007 and has a history of 17 years and four months. Its registered office is in 24 Parganas, West Bengal, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹4.00 M.
Tushar Ghosh, Pradip Ghosh, Satyajit Acharjee, and One other member serve as directors at the Company.
Company Details
- Location
24 Parganas, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24232WB2007PTC119509
- Company No.
119509
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Oct 2007
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
What products or services does Jibok Pharmaceuticals Private Limited offer?
Jibok Pharmaceuticals Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Multivitamin Syrup & Drops, Vitamin Tablets & Capsules, Methylcobalamin Tablets, Pharmaceutical Tablets, Antifungal Injection, Tablet & Syrup, Fluconazole Tablet, Pantoprazole Drugs, Pantoprazole Tablets, Antibiotic Tablets & Capsules.
Who are the key members and board of directors at Jibok Pharmaceuticals?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tushar Ghosh  | Director | 12-Oct-2007 | Current |
| Pradip Ghosh | Director | 12-Oct-2007 | Current |
| Satyajit Acharjee | Director | 12-Oct-2007 | Current |
| Rajesh Sah | Director | 12-Oct-2007 | Current |
Financial Performance of Jibok Pharmaceuticals.
Jibok Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Jibok Pharmaceuticals?
In 2017, Jibok Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Jimbiosis Healthcare Private LimitedTushar Ghosh, Pradip Ghosh and 2 more are mutual person
- North Twenty Four Healthcare Limited
Rajesh Sah is a mutual person
Charges (Loans)
₹4.00 M
₹0
Charges Breakdown by Lending Institutions
- Bank Of India : 0.40 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Apr 2018 | Bank Of India | ₹4.00 M | Open |
How Many Employees Work at Jibok Pharmaceuticals?
Jibok Pharmaceuticals has a workforce of 14 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jibok Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jibok Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
